The Non-Canonical IκB Kinases IKKε and TBK1 as Potential Targets for the Development of Novel Therapeutic Drugs

被引：4
|
作者：
Niederberger, E. [1 ]
Moeser, C. V. [1 ]
Kynast, K. L. [1 ]
Geisslinger, G. [1 ]
机构：
[1] Univ Frankfurt Klinikum, Pharmazentrum Frankfurt ZAFES, D-60590 Frankfurt, Germany
来源：
CURRENT MOLECULAR MEDICINE | 2013年 / 13卷 / 07期
关键词：
Cancer; IKK epsilon; inflammation; interferon regulatory factor; NF-kappa B; TBK1; INTERFERON REGULATORY FACTOR-3; COLLAGEN-INDUCED ARTHRITIS; TANK-BINDING KINASE-1; TOLL-LIKE RECEPTORS; RHEUMATOID-ARTHRITIS; LIVER DEGENERATION; TRANSCRIPTION FACTORS; INSULIN-RECEPTOR; SYNOVIAL TISSUE; MICE LACKING;
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
I kappa B kinase epsilon (IKK epsilon) and TANK-binding kinase 1 (TBK1) are two non-canonical IKKs which are involved in interferon regulatory factor (IRF) as well as nuclear factor kappaB (NF-kappa B) signaling cascades. Both kinases have already been linked to the pathophysiology of several diseases and therefore been suggested as potential promising targets for the development of therapeutic drugs. In this review, we summarize the roles of IKK epsilon and TBK1 in different diseases and outline therapeutic options for modulation of these kinases.
引用
收藏
页码：1089 / 1097
页数：9
相关论文
共 47 条
  • [31] TAK1 is an upstream MAP 3 K regulator of a novel non-canonical NFkB pathway stimulated by IL-1b
    Farhan, Mohammad
    McIntosh, Kathryn A.
    Cunningham, Margaret R.
    Plevin, Robin
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 708 - 709
  • [32] Constitutive and interleukin-1-inducible phosphorylation of p65 NF-κB at serine 536 is mediated by multiple protein kinases including IκB kinase (IKK)-α, IKKβ, IKKε, TRAF family member-associated (TANK)-binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATA-binding protein-associated factor II31-mediated interleukin-8 transcription
    Buss, H
    Dörrie, A
    Schmitz, ML
    Hoffmann, E
    Resch, K
    Kracht, M
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (53) : 55633 - 55643
  • [33] Design, synthesis, and biological activity of substituted 2-amino-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxylic acid derivatives as inhibitors of the inflammatory kinases TBK1 and IKKε for the treatment of obesity
    Beyett, Tyler S.
    Gan, Xinmin
    Reilly, Shannon M.
    Gomez, Andrew V.
    Chang, Louise
    Tesmer, John J. G.
    Saltiel, Alan R.
    Showalter, Hollis D.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (20) : 5443 - 5461
  • [34] Recent advances in identification of potential drug targets and development of novel drugs in parasitic diseases. Part I: Drug resistance
    Abaza, Sherif M.
    PARASITOLOGISTS UNITED JOURNAL, 2021, 14 (03) : 244 - 260
  • [35] Clinical Characteristics of POC1B-Associated Retinopathy and Assignment of Pathogenicity to Novel Deep Intronic and Non-Canonical Splice Site Variants
    Weisschuh, Nicole
    Mazzola, Pascale
    Bertrand, Miriam
    Haack, Tobias B.
    Wissinger, Bernd
    Kohl, Susanne
    Stingl, Katarina
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (10)
  • [36] Multiomics interrogation into HBV (Hepatitis B virus)-host interaction reveals novel coding potential in human genome, and identifies canonical and non-canonical proteins as host restriction factors against HBV
    Shilin Yuan
    Guanghong Liao
    Menghuan Zhang
    Yuanfei Zhu
    Weidi Xiao
    Kun Wang
    Chuanyin Li
    Caiwei Jia
    Na Sun
    Axel Walch
    Daming Gao
    Ping Xu
    Qiang Deng
    Jian Zhang
    He Wang
    Ronggui Hu
    Cell Discovery, 7
  • [37] Multiomics interrogation into HBV (Hepatitis B virus)-host interaction reveals novel coding potential in human genome, and identifies canonical and non-canonical proteins as host restriction factors against HBV
    Yuan, Shilin
    Liao, Guanghong
    Zhang, Menghuan
    Zhu, Yuanfei
    Xiao, Weidi
    Wang, Kun
    Li, Chuanyin
    Jia, Caiwei
    Sun, Na
    Walch, Axel
    Gao, Daming
    Xu, Ping
    Deng, Qiang
    Zhang, Jian
    Wang, He
    Hu, Ronggui
    CELL DISCOVERY, 2021, 7 (01)
  • [38] Therapeutic potential of TORL-4-500, an antibody-drug conjugate directed against delta like non-canonical notch ligand 1 (DLK1)
    McDermott, Martina S.
    O'Brien, Neil A.
    Lu, Ming
    Zhang, Jun
    Gong, KeWei
    Hoffstrom, Benjamin
    Luo, Tong
    Liang, Min
    Jia, Weiping
    Chau, Kevin
    Presta, Leonard
    Glaspy, John
    Slamon, Dennis J.
    CANCER RESEARCH, 2024, 84 (06)
  • [39] A novel non-canonical Notch1-IKKα-mTORC2-AKT pathway maintains survival in triple negative breast cancer cells and cancer stem-like cells
    Hossain, F.
    Peng, Y.
    Pannuti, A.
    Backus, K.
    Golde, T.
    Osborne, B.
    Miele, L.
    CANCER RESEARCH, 2017, 77
  • [40] The non-canonical BAF chromatin remodeling complex is a novel target of spliceosome dysregulation in SF3B1-mutated chronic lymphocytic leukemia
    Hagerstrand, Daniel
    Oder, Blaz
    Cortese, Diego
    Qu, Ying
    Binzer-Panchal, Amrei
    Osterholm, Cecilia
    Santos, Teresa Del Peso
    Rabbani, Leily
    Asl, Hassan Foroughi
    Skaftason, Aron
    Ljungstrom, Viktor
    Lundholm, August
    Koutroumani, Maria
    Haider, Zahra
    Jylha, Cecilia
    Mollstedt, John
    Mansouri, Larry
    Plevova, Karla
    Agathangelidis, Andreas
    Scarfo, Lydia
    Armand, Marine
    Muggen, Alice F.
    Kay, Neil E.
    Shanafelt, Tait
    Rossi, Davide
    Orre, Lukas M.
    Pospisilova, Sarka
    Barylyuk, Konstantin
    Davi, Frederic
    Vesterlund, Mattias
    Langerak, Anton W.
    Lehtio, Janne
    Ghia, Paolo
    Stamatopoulos, Kostas
    Sutton, Lesley-Ann
    Rosenquist, Richard
    LEUKEMIA, 2024, 38 (11) : 2382 - 2394
12345